What are the Training Schools?
COST ACTION networks can share knowledge and support collaboration through Training Schools. Training Schools are organised around research topics and provide dissemination opportunities for the activities of the COST action. TS provide intensive training in emerging research topics within the laboratories and organisations involved in the COST Actions. They are not intended to provide general training. They also offer familiarisation with unique equipment or expertise and are typically but not exclusively for young researchers (ECI-early career investigator, PhD students and <8 years Post-PhD), involved in COST Actions. Training Schools also cover appropriate re-training as part of life-long learning.

ENIUS Training Schools aim to

• Widen the knowledge of urinary stents.
• Provide intensive training on a new and emerging subject related to urinary stents.
• Offer familiarisation with unique equipment or new methods in one of the laboratories of the Action.
• Provide lectures and roundtable discussions, as well as practical training. Trainers are a key ingredient of our TS and we select them with great care.

The duration of a Training School is normally between 2-4 days.

Training Schools

“Ureteral stents: from modelling to commercialisation”

Tuesday 10th – Wednesday 11th September 2019
More Information

Local Organising Committee

Prof. Sarah Waters, University of Oxford, UNITED KINGDOM – ENIUS working group leader
Dr. Francesco Clavica, University of Bern, SWITZERLAND – ENIUS working group vice-leader
Dr. Dario Carugo, University of Southampton, UNITED KINGDOM – ENIUS Short term Scientific Mission (STSM) coordinator


Diana Bethge, e-mail: diana.bethge@artorg.unibe.ch
Dr Francesco Clavica, e-mail: francesco.clavica@artorg.unibe.ch
Prof. Sarah Waters, e-mail: sarah.waters@maths.ox.ac.uk
Dr Dario Carugo, e-mail: d.carugo@soton.ac.uk

Advances in Urinary Stents. Biomaterials, Coatings and Drug Eluting Stents (DES)

26th-27th - September, 2019. Lublin (Poland).

More Information

Urinary stents (ureteral-urethral, polymeric-metallic), are routinely used. They have many indications, but their main function is to facilitate urine drainage, as internal scaffolds, in cases of urinary obstruction caused by lithiasis, cancer, benign disease, surgery, kidney transplant, etc. However, despite their great usefulness, urinary stents are associated to big side effects and complications that reduce their efficacy. This leads to a significant impairment in the patient’s quality of life and to an increase in health costs.

As part of ENIUS, we developed two Working groups:

WG4. Biomaterials and stent coatings. The WG4 will work on the search of new biomaterials-nanomaterials and coatings with improved behavior at urinary tract level when used for manufacturing stents. The aim with this WG is to determine the characteristics of the new biomaterials and coatings (polymeric, non-polymeric, biodegradables and/or metallic) that are involved in the improvement of stent success rate and stent-related morbidity.

WG5. Drug Eluting Stents (DESs) (M20-M48). Following the idea of incorporating drugs onto the stent surface, several substances have already been used in DESs in an attempt to diminish stent-related adverse effects. An alternative novel tool for the confrontation of urothelial hyperplasia or Urinary tract infection following metallic stenting is expected to be provided from the use of DESs. It is expected that with the improvement of the designs, Nano-Technology, making them more biocompatible, their features will be optimized and reduce side effects. The use of DESs in the ureter and urethra has been limited to few experimental studies. It remains to be proven if the promising benefit of DESs will eventually become a part of urological practice.

We consider that the absence of an interdisciplinary network is the most important factor responsible for stent related morbidity. For this reason, engineers, researchers and urologist should meet and share needs and proposals for improvement in urinary stents.

Aims and Objectives

This training School will bring together a multidisciplinary group of engineers, researchers and urologists. We will present the Complications, Impact of Quality of life, future developments in Urinary Stents (Biomaterials, Coatings and drug eluting stents)

The aims of the Training School are:

  1. To consolidate a multidisciplinary network (urologist, translational researchers, bioengineers, etc) actively involved in urinary stent research to facilitate scientific knowledge exchange between young researchers.
  2. To create a cohort of skilled bioengineer/researchers with experience in Urinary stents
We are processing your form, please wait.